prostate cancer

Open Access
Comparing Efficacy Between Robust and PTV Margin-based Optimizations for Interfractional Anatomical Variations in Prostate Tomotherapy
TAKAYUKI YAGIHASHI, TATSUYA INOUE, SHINTARO SHIBA, AKIHIRO YAMANO, MASASHI YAMANAKA, NAOKI SATO, KAZUMASA INOUE, MOTOKO OMURA and HIRONORI NAGATA

In Vivo January 2024, 38 (1) 409-417; DOI: https://doi.org/10.21873/invivo.13453
Open Access
Clinical Course of Candidate Renal Transplant Recipients Diagnosed With Prostate Cancer During Pre-transplant Screening Test
YUKI KOBARI, JUNPEI IIZUKA, CHIKA NAGAHISA, RYO MINODA, KOHEI UNAGAMI, KAZUHIKO YOSHIDA, TOSHIHITO HIRAI, TOMOKAZU SHIMIZU, HIDEKI ISHIDA and TOSHIO TAKAGI

In Vivo January 2024, 38 (1) 496-499; DOI: https://doi.org/10.21873/invivo.13465
Open Access
Comparison of Distress Scores Before and After Radiotherapy for Prostate Cancer
STEFAN JANSSEN, CANSU DELIKANLI, NATHAN Y. YU and DIRK RADES

In Vivo September 2023, 37 (5) 2173-2177; DOI: https://doi.org/10.21873/invivo.13316
Open Access
Over-expression of Long Non-coding RNA Urothelial Cancer-associated 1 as a Predictive Marker for Prostate Cancer
YOO JIN LEE, SUNG GU KANG and CHUL HWAN KIM

In Vivo July 2023, 37 (4) 1511-1516; DOI: https://doi.org/10.21873/invivo.13236
Open Access
⁶⁸Ga-PSMA PET/CT and Prostate Cancer Diagnosis: Which SUVmax Value?
PIETRO PEPE, LUDOVICA PEPE, MARIA TAMBURO, GIULIA MARLETTA, FRANCESCO SAVOCA, MICHELE PENNISI and FILIPPO FRAGGETTA

In Vivo May 2023, 37 (3) 1318-1322; DOI: https://doi.org/10.21873/invivo.13211
Open Access
Prostate-specific Antigen Levels Following Brachytherapy Impact Late Biochemical Recurrence in Japanese Patients With Localized Prostate Cancer
YOSHITERU UENO, TOMOHARU FUKUMORI, YOSHITO KUSUHARA, TOMOYA FUKAWA, MEGUMI TSUDA, KEI DAIZUMOTO, YUTARO SASAKI, RYOTARO TOMIDA, YASUYO YAMAMOTO, KUNIHISA YAMAGUCHI, CHISATO TONOISO, AKIKO KUBO, TAKASHI KAWANAKA, SHUNSUKE FURUTANI, HITOSHI IKUSHIMA, MASAYUKI TAKAHASHI and HIRO-OMI KANAYAMA

In Vivo March 2023, 37 (2) 738-746; DOI: https://doi.org/10.21873/invivo.13136
Open Access
Moderately Hypofractionated Helical Tomotherapy for Prostate Cancer: Ten-year Experience of a Mono-institutional Series of 415 Patients
SALVATORE COZZI, MARIA PAOLA RUGGIERI, EMANUELE ALÌ, SEBASTIANO FINOCCHI GHERSI, FEDERICA VIGO, MATTEO AUGUGLIARO, LUCIA GIACCHERINI, FEDERICO IORI, MASOUMEH NAJAFI, LILIA BARDOSCIA, ANDREA BOTTI, VALERIA TROJANI, PATRIZIA CIAMMELLA and CINZIA IOTTI

In Vivo March 2023, 37 (2) 777-785; DOI: https://doi.org/10.21873/invivo.13141
Open Access
Assessment of Prostate Volume and Prostate-specific Antigen Density With the Segmentation Method on Magnetic Resonance Imaging
YEN-TING LIN, SIU-WAN HUNG, KUN-YUAN CHIU, JYH-WEN CHAI and JIN-CHING LIN

In Vivo March 2023, 37 (2) 786-793; DOI: https://doi.org/10.21873/invivo.13142
Open Access
Distinct Expression of Surface and Genetic Biomarkers in Prostate Cancer Cell Lines
CHEN-YING SU, GWO-CHE HUANG, I-CHENG CHEN, PEI-YU CHEN, YU-JEN CHEN and HSU-WEI FANG

In Vivo January 2023, 37 (1) 242-246; DOI: https://doi.org/10.21873/invivo.13073
Open Access
Chemosensitizing Effect and Efficacy of Wilforlide A in Combination With Docetaxel in Drug-resistant Prostate Cancer
ZHIJUN WANG, STEVEN YEUNG, SHANCHAO YANG, YING HUANG and MOSES SING SUM CHOW

In Vivo September 2022, 36 (5) 2020-2031; DOI: https://doi.org/10.21873/invivo.12928

Main menu

User menu

Search

prostate cancer

Pages